Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.
about
Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantationProducer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumorsCAR T cells for solid tumors: armed and ready to go?Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationInducible apoptosis as a safety switch for adoptive cell therapyEngineered T cells for cancer treatmentLentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes.Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.Immunotherapy in acute leukemiaLong-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgeneIL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice.The basic principles of chimeric antigen receptor design.A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy.Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.Immunotherapy of human cancers using gene modified T lymphocytes.Use of tumour-responsive T cells as cancer treatment.Genome editing in mouse spermatogonial stem/progenitor cells using engineered nucleases.Adoptive T cell therapy of cancer.Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.Survivin-specific T cell receptor targets tumor but not T cells.Engineered T cells for pancreatic cancer treatmentIn Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33 Acute Myeloid LeukemiaIL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.Genetically modified T-cell therapy for osteosarcomaAnti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humansGenetic modification of human T lymphocytes for the treatment of hematologic malignancies.Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cellsCAR-T Cell Therapy for Lymphoma.Selective expansion and enhanced anti-tumor effect of antigen-specific CD4(+) T cells by retrovirus-mediated IL-15 expressionVisualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer.Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphomaT cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive MalignanciesAdoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.Immunotherapies for Hodgkin's lymphoma.Adoptive cellular immunotherapy for childhood malignancies.Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients.Genetically modified T cells targeting neovasculature efficiently destroy tumor blood vessels, shrink established solid tumors and increase nanoparticle deliveryDevelopment of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition
P2860
Q24642254-849FCB9C-DC1D-4FD8-B804-4568C0F0286BQ26741260-B8B3E4F1-EBB0-4273-B971-54C9451F1EE4Q26825489-13DB45D6-61A2-44EC-96C1-3D5FD6295DD4Q28068378-71C26ADC-CDCB-4238-B61E-2922F4B4B6F7Q29617710-125706DE-FAFD-4CCB-A974-08F2AA0A17DAQ33578792-DAA26A74-912D-4BA9-B236-9E004DFF34F2Q33688441-4DCF17F1-EB5E-4B35-8545-E0AE0C758222Q33713042-BEF1C2FA-5140-4D50-800E-3E5D5411F8DAQ33731552-B21FA30D-68D6-413F-BDC6-1F150AF1811BQ33781162-A450E114-F46E-49EE-91B8-D5137241547DQ33839836-A0A50404-1E2E-484D-A333-F74C3921FB72Q34036213-5ED09145-1E9C-4203-966A-4AF00D6F2D55Q34044757-A568A30C-C171-4A04-B56D-83C7BC94511DQ34122292-F948C041-AB08-448F-B609-4B1449963A6BQ34163218-17ED67AA-49C8-4C40-8AB1-5A4ED207CFF4Q34188383-01675F34-BD58-4E1C-A8C7-A8AB9C359861Q34285656-38664D47-1A4D-4201-9DCA-E7E1A4466038Q34542214-5B57B3B6-C3DB-4D83-8B80-47D96F515053Q34977470-CFF29B7D-5612-4875-8E28-71E59C06B8EEQ35222179-DC518F70-4F79-40B5-8BDF-1722B1256349Q35242576-863AE338-DF97-48FF-ACBB-7889F8B4EAD1Q35244233-EDC9AFC9-E0E0-45B6-A6CF-2FBD0A11E474Q35681332-360713E7-AA0F-47F3-B396-91B58CDAE0B5Q36005345-2A5F320C-5802-476D-B978-CE1561C17BBEQ36198232-93FEBB49-57BE-436A-9C57-BF57173CB3C9Q36239694-0BF5DD7C-0B06-4D76-9973-6BE33AEBFA56Q36366557-74FED343-4E95-4FFD-9942-8D39C266E4DDQ36429491-997ED649-3206-40A1-B4AC-9D9F66E36144Q36470354-FD2DD334-720B-4D5E-8DBD-06A3DAFBB426Q36519358-47D7430A-B486-4A98-AFB4-C805E04200ABQ36922752-74996FDA-8ABF-48FB-B694-35D4B3736566Q36936395-1ED7CD2B-7D2B-4852-96C0-5125B20D21D2Q36956269-0F3B027D-D85A-4028-B5FD-20293F4F5EB5Q36965071-51940B40-8CA2-44AC-9203-D645DF610D5DQ37002020-E0A828FF-FAEB-493D-980B-41AB0AEEB6C6Q37006427-9D09E544-FE41-429D-BCE9-B6AFD98156FAQ37008216-EFA00C93-3C71-4493-9C61-B64EE9CAAA5BQ37129671-04E09030-9AEC-4963-93BD-15F93A932A41Q37164976-08CE0456-AFAB-4838-A292-420692BC3956Q37197942-86635164-DEE7-4542-94B0-41A2DF83D10C
P2860
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Co-expression of cytokine and ...... cific cytotoxic T lymphocytes.
@ast
Co-expression of cytokine and ...... cific cytotoxic T lymphocytes.
@en
type
label
Co-expression of cytokine and ...... cific cytotoxic T lymphocytes.
@ast
Co-expression of cytokine and ...... cific cytotoxic T lymphocytes.
@en
prefLabel
Co-expression of cytokine and ...... cific cytotoxic T lymphocytes.
@ast
Co-expression of cytokine and ...... cific cytotoxic T lymphocytes.
@en
P2093
P2860
P1433
P1476
Co-expression of cytokine and ...... ecific cytotoxic T lymphocytes
@en
P2093
Aaron E Foster
Barbara Savoldo
Cliona M Rooney
Gianpietro Dotti
Greta M P Giordano Attianese
Helen E Heslop
Juan F Vera
Malcolm K Brenner
P2860
P304
P356
10.1182/BLOOD-2007-02-072843
P407
P577
2007-07-17T00:00:00Z